Delivery of beclomethasone dipropionate from a spacer device: what dose is available for inhalation?

O'Callaghan, C; Cant, M; Robertson, C
October 1994
Thorax;Oct1994, Vol. 49 Issue 10, p961
Academic Journal
No abstract available.


Related Articles

  • The Effect of Spacer Morphology on the Aerosolization Performance of Metered-Dose Inhalers. Momeni, Sepideh; Nokhodchi, Ali; Ghanbarzadeh, Saeed; Hamishehkar, Hamed // Advanced Pharmaceutical Bulletin;Jun2016, Vol. 6 Issue 2, p257 

    Purpose: Respiratory drug delivery has been attracted great interest for the past decades, because of the high incidence of pulmonary diseases. However, despite its invaluable benefits, there are some major drawbacks in respiratory drug delivery, mainly due to the relatively high drug deposition...

  • NEW DEVICES.  // Pharmacy Today;Jul2014, Vol. 20 Issue 7, p19 

    The article reports on the approval by the U.S. Food and Drug Administration (FDA) the use of beclomethasone dipropionate HFV for the treatment of asthma and the insulin detemir injection from Levemir FlexTouch as an insulin delivery device.

  • Beclometasone Dipropionate/Formoterol in an HFA-Propelled Pressurised Metered-Dose Inhaler. Chung, K. F. // Drugs;2006, Vol. 66 Issue 11, p1485 

    The article reports on the combination therapy of inhaled corticosteroids and long-acting B2-agonist. The combination therapy of these two drugs became an established treatment for patients with symptomatic and moderately severe asthma. Examples of the combination of inhaled corticosteroids and...

  • Influence of Delivery Devices on Efficacy of Inhaled Fluticasone Propionate: A Comparative Study in Stable Asthma Patients. KOLASANI, BHANU PRAKASH; LANKE, VENU MADHAVI; DIYYA, SUDHEER // Journal of Clinical & Diagnostic Research;Sep2013, Vol. 7 Issue 9, p1908 

    Background: Inhaled corticosteroids are the preferred treatment for long-term control of all grades of persistent asthma. These are administered by various delivery devices with very little information whether these devices can affect the efficacy of inhaled corticosteroids. Fluticasone...

  • Adrenal suppression by inhaled corticosteroids in patients with asthma: A systematic review and quantitative analysis. Wojciechowski, Piotr; Dziewonska, Marta; Rys, Przemyslaw; Kowalski, Marek L. // Allergy & Asthma Proceedings;Jan/Feb2016, Vol. 37 Issue 1, p9 

    Background: Inhaled corticosteroids used for treating persistent asthma can suppress adrenal cortisol secretion. This inhibition of endogenous cortisol secretion is an important marker of systemic steroid activity. Although meta-analyses have demonstrated a dose-dependent suppression of cortisol...

  • Pulmonary and Nasal Anti-Inflammatory and Anti-Allergy Inhalation Aerosol Delivery Systems. Xiao Wu; Adedoyin, Oreoluwa O.; Mansour, Heidi M. // Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry;Jun2011, Vol. 10 Issue 3, p215 

    Most respiratory infections, diseases and allergic reactions have varying degrees of inflammation. Inflammation is a natural immunodefensive response to the presence of allergens or foreign particles that come into contact or affect the cells and tissues within the respiratory tract. The three...

  • Comparison of a Multidose Powder Inhaler Containing Beclomethasone Dipropionate (BDP) with a BDP Metered Dose Inhaler with Spacer in the Treatment of Asthmatic Patients. Lähelmä, S.; Poukkula, A.; Paananen, M.; Alanko, K.; Ruotsalainen E.-M.; Kilpiö, K.; Salomaa E.-R.; Knuuttila, A.; Silvasti, M.; Koskinen, S.; Suuronen, U.; Laitinen, J.; Toivanen, P.; Lehtonen, K.; Vilkka, V.; Liippo, K.; Lindqvist, A. // Clinical Drug Investigation;1998, Vol. 16 Issue 2, p101 

    Objective: The clinical efficacy, tolerability and acceptability of a new multidose powder inhaler (MDPI) [Easyhaler, Orion Pharma, Finland] containing a high dose (500 µg/dose) of beclomethasone dipropionate (BDP) were compared with those of BDP metered dose inhaler administered with a large...

  • Esophageal candidiasis as a side effect of inhaled fluticasone propionate dry powder: recovery by switching over to hydrofluoroalkane-134a beclomethasone dipropionate (HFA-BDP). Kobayashi, Y.; Yasuba, H.; Kudou, M.; Hamada, K.; Kita, H. // International Journal of Clinical Pharmacology & Therapeutics;2006, Vol. 44 Issue 5, p193 

    Background: Esophageal candidiasis is one of the local side effects of inhaled corticosteroid treatment, and it is difficult to prevent this condition. Our previous report indicated that the prevalence of esophageal candidiasis among patients treated with inhaled fluticasone propionate dry...

  • Choosing Therapy for Childhood Asthma. Holgate, Stephen T.; Frew, Anthony J. // New England Journal of Medicine;12/04/97, Vol. 337 Issue 23, p1690 

    Editorial. Focuses on choosing a therapy for childhood asthma. The availability of inhaled corticosteroids, cromolyn sodium or nedocromil sodium, beclomethasone dipropionate and salmeterol; Other options, such as environmental interventions; Reference to work by Simons et al in same issue.

  • Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the In Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder Inhaler. Buttini, Francesca; Pasquali, Irene; Brambilla, Gaetano; Copelli, Diego; Alberi, Massimiliano; Balducci, Anna; Bettini, Ruggero; Sisti, Viviana // Pharmaceutical Research;Mar2016, Vol. 33 Issue 3, p701 

    Purpose: The aim of this work was to evaluate the effect of two different dry powder inhalers, of the NGI induction port and Alberta throat and of the actual inspiratory profiles of asthmatic patients on in-vitro drug inhalation performances. Methods: The two devices considered were a reservoir...


Read the Article


Sign out of this library

Other Topics